- Home
- TERN vs RA Comparison
TERN vs RA Comparison
Compare TERN & RA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- RA
- Stock Information
- Founded
- TERN 2017
- RA 2016
- Country
- TERN United States
- RA United States
- Employees
- TERN N/A
- RA 1260
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- RA Investment Managers
- Sector
- TERN Health Care
- RA Finance
- Exchange
- TERN Nasdaq
- RA Nasdaq
- Market Cap
- TERN 713.2M
- RA 711.7M
- IPO Year
- TERN 2021
- RA N/A
- Fundamental
- Price
- TERN $8.39
- RA $13.04
- Analyst Decision
- TERN Buy
- RA
- Analyst Count
- TERN 7
- RA 0
- Target Price
- TERN $14.99
- RA N/A
- AVG Volume (30 Days)
- TERN 1.1M
- RA 280.8K
- Earning Date
- TERN 11-11-2025
- RA 01-01-0001
- Dividend Yield
- TERN N/A
- RA 14.73%
- EPS Growth
- TERN N/A
- RA N/A
- EPS
- TERN N/A
- RA N/A
- Revenue
- TERN N/A
- RA N/A
- Revenue This Year
- TERN N/A
- RA N/A
- Revenue Next Year
- TERN N/A
- RA N/A
- P/E Ratio
- TERN N/A
- RA N/A
- Revenue Growth
- TERN N/A
- RA N/A
- 52 Week Low
- TERN $1.87
- RA $11.89
- 52 Week High
- TERN $9.03
- RA $17.32
- Technical
- Relative Strength Index (RSI)
- TERN 58.46
- RA 31.68
- Support Level
- TERN $7.91
- RA $13.39
- Resistance Level
- TERN $9.03
- RA $13.54
- Average True Range (ATR)
- TERN 0.42
- RA 0.13
- MACD
- TERN -0.01
- RA -0.05
- Stochastic Oscillator
- TERN 59.43
- RA 10.41
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.